Skip to content

Saliva-Based Digital Infection Testing Technology

Nanotis > news > We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program

We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program

We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program. See more

We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program 5/30/2024
Started a collaborative research with the Influenza Virus Research Center at the National Institute of Infectious Diseases 11/15/2023
Raised from Niporo Corporetion 7/15/2022
Nanotis, a UTokyo-affiliated startup, is raising funds in the pre seed finance to accelerate the development of next-generation infection testing devices 4/15/2021
Nanotis, a UTokyo-affiliated startup,
receives funding from Taisho Pharmaceutical for R&D of rapid diagnostic devices 5/20/2020

Nanotis Corporation
Established in June 2016
Tokyo, Japan